(Q73085477)

English

The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer

scientific article published on 01 December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

W K Evans

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Le Chevalier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

32A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2249-2255

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic and therapeutic approaches to lung cancer in Canada and their costs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life during chemotherapy in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Does knowledge guide practice? Another look at the management of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in patients with non-small cell lung cancer treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900298-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(96)00298-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9038606%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73085477&oldid=1743422453"